Home » University of Illinois Cancer Center Strategic Alliance Partnership: OncLive

University of Illinois Cancer Center Strategic Alliance Partnership: OncLive

Video: Gadi on AMUN-003 in Triple-Negative Breast Cancer

Watch this OncLive interview with University of Illinois Cancer Center Deputy Director VK Gadi, MD, PhD, about AMUN-003 in triple-negative breast cancer, a newly developed oncolytic adenovirus that…

Dr. Jain Discusses the Driving Forces of Gender Inequities in Medicine

Shikha Jain, MD, FACP discusses an article she authored, titled “We’re Running Up the Wrong Side of the Escalator,” which confronts systemic and structural obstacles facing women in medicine. OncLi…

Episode 2: Updates in the Treatment of HER2+ and HER2-Low Breast Ca…

HER2 Dual Blockade in Early Stage HER2+ Breast Cancer Dr. VK Gadi and an expert panel of oncologists share insight on the optimal use of HER2 dual-blockade strategies in patients […]

Episode 1: Updates in the Treatment of HER2+ and HER2-Low Breast Ca…

Early Stage HER2+ Breast Cancer: Overview of Adjuvant Treatment Dr. VK Gadi and a panel of expert oncologists review adjuvant treatment strategies in early stage HER2+ breast cancer and consider [&…

Dr. Feldman on Lenvatinib and Pembrolizumab Plus Chemotherapy in NSCLC

Cancer Center Member Lawrence E. Feldman, MD, discusses the phase 3 LEAP-006 trial evaluating lenvatinib and pembrolizumab plus chemotherapy in non–small cell lung cancer.

Dr. Weinberg on Treating Patients with NTRK Fusions in NSCLC

Frank Weinberg, MD, PhD, discusses the treatment options in non–small cell lung cancer harboring NTRK fusions.

Episode 13: The Changing Treatment Paradigm of HER2+ Metastatic Bre…

Evolving Treatment Landscape of HER2+ Metastatic Breast Cancer

Episode 12: The Changing Treatment Paradigm of HER2+ Metastatic Bre…

Treatment Options for HER2+, ER+ Metastatic Breast Cancer

Episode 11: The Changing Treatment Paradigm of HER2+ Metastatic Bre…

Special HER2+ mBC Populations: HR+ or HER2-Low Patients

Episode 10: The Changing Treatment Paradigm of HER2+ Metastatic Bre…

Potential Role of Surgery in HER2+ Metastatic Breast Cancer

Episode 9: The Changing Treatment Paradigm of HER2+ Metastatic Brea…

SABCS 2021: Small Molecule Clinical Trials in R/R HER2+ mBC

Episode 8: The Changing Treatment Paradigm of HER2+ Metastatic Brea…

SABCS 2021: Combination Strategies Under Investigation for R/R HER2+ mBC

Episode 7: The Changing Treatment Paradigm of HER2+ Metastatic Brea…

HER2+ Breast Cancer: Updates on HER2CLIMB and CNS Disease Management

Episode 6: The Changing Treatment Paradigm of HER2+ Metastatic Brea…

Novel Treatment Approaches to R/R HER2+ Metastatic Breast Cancer

Episode 5: The Changing Treatment Paradigm of HER2+ Metastatic Brea…

HER2+ mBC: Impact of T-DM1 and T-DXd Beyond the Frontline Setting

Episode 4: The Changing Treatment Paradigm of HER2+ Metastatic Brea…

Monitoring Patients With HER2+ Metastatic Breast Cancer

Episode 3: The Changing Treatment Paradigm of HER2+ Metastatic Brea…

Patient Case: Frontline Treatment Options for HER2+ mBC

Episode 2: The Changing Treatment Paradigm of HER2+ Metastatic Brea…

Patient Case: Biomarker Testing in Breast Cancer

Episode 1: The Changing Treatment Paradigm of HER2+ Metastatic Brea…

An Overview on the Current State of Metastatic Breast Cancer

Dr. Spaggiari on Surgical Strategies to Improve Liver Remnants in C…

Mario Spaggiari, MD, transplant surgeon, Division of Transplantation, University of Illinois Health, discusses surgical interventions in colorectal cancer (CRC) with liver metastases.

Dr. Spaggiari on Considerations for Patients With CRC and Liver Met…

Mario Spaggiari, MD, transplant surgeon, discusses considerations for patients with colorectal cancer (CRC) and liver metastases who have no surgical options.

Dr. Jain on the Push Toward Personalized Treatment Approaches in CR…

Shikha Jain, MD, FACP, discusses the push toward personalized treatment approaches in colorectal cancer with liver metastases. The University of Illinois Cancer Center serves as a Strategic Allianc…

Dr. Spaggiari on the Potential Utility of Liver Transplantation in …

Mario Spaggiari, MD, discusses the potential utility of liver transplantation as a treatment option for patients with colorectal cancer liver metastases The University of Illinois Cancer Center ser…

Dr. Jain on the Importance of Communication for Multidisciplinary C…

Shikha Jain, MD, FACP, discusses the importance of communication in patients with colorectal cancer and liver metastases who are receiving multidisciplinary care. The University of Illinois Cancer …

Dr. Jain on the Need to Enroll Heterogenous Populations to Clinical…

Shikha Jain, MD, FACP, discusses the need to enroll heterogenous patient populations to clinical trials in colorectal cancer. The University of Illinois Cancer Center serves as a Strategic Alliance…

Dr Gadi on screen leading a panel of experts in a discussion

Dr. Gadi on Preferences for Treating Relapsed HER2+ Metastatic Brea…

Dr. VK Gadi, leads a panel discussion of breast oncologists highlighting their therapy preferences for a woman with HER2-positive metastatic breast cancer previously treated with docetaxel-trastuzu…

Mario Spaggiari giving a presentation on a laptop computer

Dr. Spaggiari on Surgical Interventions in CRC With Liver Metastase…

Mario Spaggiari, MD, transplant surgeon, Division of Transplantation, University of Illinois Health, discusses surgical interventions in colorectal cancer (CRC) with liver metastases.

Dr. Simons' presentation on a computer screen

Dr. Simons on the Correlation of Somatic Gene Alterations and Resis…

Yael Simons, MD, a Hematology/Oncology fellow speaks on racial disparities in patient outcomes with luminal breast cancer.

Dr. Simons video shown on a computer screen

Dr. Simons on Racial Disparities Reported in Luminal Breast Cancer:…

Yael Simons, MD, a Hematology/Oncology fellow speaks on racial disparities in patient outcomes with luminal breast cancer.

OncLive Video: Enrollment disparities in pivotal clinical trials

Chief Fellow Dr. Ryan Nyugen discussed findings of his health disparities research with OncLive, noting that across all tumor types, Black patients were less than one-third as likely to be […]

Dr. Kent Hoskins on the Impact of Race on Breast Cancer Outcomes

Underrepresentation in research hinders treatment for Black women with breast cancer, University of Illinois Cancer Center member Dr. Kent Hoskins told OncLive. A key question for researchers: Do s…

Translate »